Molecular Modelling of Potential Candidates for the Treatment of Depression
- 27 May 2019
- journal article
- research article
- Published by Wiley in Molecular Informatics
- Vol. 38 (7) , e1900024
Abstract
A lot of research initiatives in the last decades have been focused on the search of new strategies to treat depression. However, despite the availability of various antidepressants, current treatment is still far from ideal. Unwanted side effects, modest response rates and the slow onset of action are the main shortcomings. As a strategy to improve symptomatic relief and response rates, the dual modulation of the serotonin transporter and the histamine H3 receptor by a single chemical entity has been proposed in the literature. Accordingly, this work aims to elucidate key structural features responsible for the dual inhibitory activity of the hexahydro‐pyrrolo‐isoquinoline derivatives. For this purpose, two approaches were employed, four‐dimensional quantitative structure‐activity relationship (4D‐QSAR) and molecular docking. The 4D‐QSAR models for both receptors allowed the identification of the pharmacophore groups critical for the modelled biological activity, whereas the binding mode of this class of compounds to the human serotonin transporter was assessed by molecular docking. The findings can be applicable to design new antidepressants.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo ao Ensino e Pesquisa de Minas Gerais
This publication has 33 references indexed in Scilit:
- 4D-QSAR: Perspectives in Drug DesignMolecules, 2010
- On Two Novel Parameters for Validation of Predictive QSAR ModelsMolecules, 2009
- Location of the Antidepressant Binding Site in the Serotonin TransporterJournal of Biological Chemistry, 2009
- Basic validation procedures for regression models in QSAR and QSPR studies: theory and applicationJournal of the Brazilian Chemical Society, 2009
- Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approachChemico-Biological Interactions, 2008
- Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Principles of QSAR models validation: internal and externalQSAR & Combinatorial Science, 2007
- Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- MolDock: A New Technique for High-Accuracy Molecular DockingJournal of Medicinal Chemistry, 2006
- 4D-QSAR Models of HOE/BAY-793 Analogues as HIV-1 Protease InhibitorsQSAR & Combinatorial Science, 2005